SCOTUS Passes on Three IPR Petitions for Cert, but Arthrex Petition Still in Play
June 24, 2020
By: Mark McCarty
BioWorld / BioWorld MedTech
Axinn partner Aziz Burgy was quoted in the BioWorld and BioWorld MedTech article, "SCOTUS Passes on Three IPR Petitions for Cert, but Arthrex Petition Still in Play.”
Click here to access the article. A subscription is required.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
IBA Annual Conference 2025
Speaking Engagement
Antitrust
Thomson Reuters 24th Annual Law Firm COO & CFO Forum
Speaking Engagement
LegalNEXT 2025
Speaking Engagement
Antitrust
Informa Antitrust Texas 2025
Speaking Engagement
Antitrust
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
MCCA Gala 2025
Sponsorship
Antitrust
Antitrust 101: Trial-Minded Antitrust Discovery
Webinar
Antitrust
ABA Antitrust Plaintiffs' Roundtable 2025
Speaking Engagement
Antitrust
Centerforce IP Strategy Summit: Palo Alto
Speaking Engagement
Intellectual Property
Corporate Counsel Women, Influence, & Power in Law Conference 2025
Speaking Engagement
Antitrust